Latest News for: cvid

Edit

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation (Pharming Group NV)

Public Technologies 20 Mar 2025
CVID patients demonstrate clinical phenotypes similar to APDS, with global prevalence estimated at approximately 39 per million ... variable immunodeficiency (CVID) patients with immune dysregulation.
Edit

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation (Form 6-K) (Pharming Group NV)

Public Technologies 20 Mar 2025
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation ... CVID patients demonstrate clinical ...
  • 1
×